Keurig Dr Pepper nears $18 billion deal for JDE Peet's, WSJ reports-February 2024-www.financetom.com

Keurig Dr Pepper nears $18 billion deal for JDE Peet's, WSJ reports

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Keurig Dr Pepper nears $18 billion deal for JDE Peet's, WSJ reports

Aug 24, 2025 2:55 PM

Aug 24 (Reuters) - Keurig Dr Pepper ( KDP ) is close to

a roughly $18 billion deal for European coffee company JDE

Peet's, the Wall Street Journal reported on Sunday,

citing people familiar with the matter.

Reuters could not immediately verify the report.

Previous page： CureVac Says Phase 2 Interim Data Show Multivalent Flu Vaccine Candidate Boosts Antibody Titers Next page： Goldman Sachs urged to separate CEO and chair roles by proxy advisers

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

CureVac Says Phase 2 Interim Data Show Multivalent Flu Vaccine Candidate Boosts Antibody Titers

Apr 4, 2024

11:25 AM EDT, 04/04/2024 (MT Newswires) -- CureVac ( CVAC ) said Thursday that interim data from an ongoing phase 2 part of a combined phase 1/2 study showed that its multivalent influenza vaccine candidate boosted antibody titers against all four encoded flu strains and has an acceptable safety and tolerability profile. The company said the multivalent vaccine candidate, which...

Goldman Sachs urged to separate CEO and chair roles by proxy advisers

Apr 4, 2024

April 4 (Reuters) - Goldman Sachs ( GS ) should separate the CEO and chairman roles currently held by David Solomon, proxy adviser Glass Lewis wrote in a report on Thursday. The recommendation to shareholders followed a similar suggestion from Institutional Shareholder Services on Wednesday. Glass Lewis said having an independent chair is nearly always preferable to having a single...

Can Tesla Stock Really Hit $2,000? Cathie Wood Thinks So

Apr 4, 2024

Tesla (TSLA) stock is down more than 30% so far in 2024, but Ark Invest CEO Cathie Wood thinks now is not the time to run for the hills. In fact, Ark has been buying the stock and thinks it could rise to $2,000 per share in the next five years, representing an increase of more than 1,000% from today's...

Charles River Laboratories Signs Plasmid DNA Manufacturing Deal With Ship of Theseus

Apr 4, 2024

11:29 AM EDT, 04/04/2024 (MT Newswires) -- Charles River Laboratories International ( CRL ) will help therapeutics company Ship of Theseus produce good manufacturing practice-grade plasmid DNA to serve as the active drug substance for its lead candidate, the companies said Thursday. The collaboration will support therapeutic development for various target indications, including diabetic and chronic wounds, women's health and...